de la Fuente, A., Santisteban, M., Lupón, J., Aramendía, J. M., Díaz, A., Santaballa, A., . . . Ravassa, S. (2022). A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy.
Citação norma Chicagode la Fuente, Ana, et al. A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy. 2022.
Citação norma MLAde la Fuente, Ana, et al. A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy. 2022.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.